Latest Posters

This poster demonstrates how a novel, precise and highly controlled iPSC reprogramming technology overcomes these limitations and enables the generation of mature cell types and isogenic models of neurodegenerative disease.

Many promising drugs which show efficacy in animal models have failed in the clinic due to interspecies variance in nociception mechanisms. Hence, consistent, scalable human in vitro models are required to accelerate potential therapeutics to the clinic.

While animal models and primary cells remain valuable resources, neuronal drug development faces many challenges. Not least, the variability and inaccuracy of traditional model systems can result in the failure to translate data into successful clinical trials.

Drug discovery is a time-consuming, resource-intensive part of developing therapeutic targets. This is especially true for commonly considered 'undruggable' targets such as transmembrane proteins.

Traditionally, there has been a compromise between performance and sustainability.

Researchers looking to answer complex biological questions often require increased statistical power, larger studies and deeper sequencing methods.

2D cultures often fall short in drug screening when it comes to clinical predictivity, but 3D models and high content services allow accurate and clinically relevant screens.

Download this poster to learn more about organelle marker antibodies, stains for live-cell or fixed-cell imaging and finding the right antibodies and dyes for your organelle research.

Laboratory automation has become ubiquitous in many pharmaceutical and biotechnology laboratories and supports a wide range of applications including drug discovery and development, synthetic biology, food and animal health, clinical diagnostics and many others.

The potential of human pluripotent stem cells (hPSCs) continues to show incredible promise, rapidly progressing through clinical trials for use in treatment of a multitude of diseases. However, historical methods of hPSC culture have remained a barrier of entry into the clinic even with relative success within in vitro cellular research.